The reduced dry times apply to several CareFusion ChloraPrep products, including Sepp, Frepp, Single and Triple Swabsticks. These products have a reduced dry time on dry surgical sites of 30 seconds ...

LEAWOOD, Kan., Nov. 1 /PRNewswire/ -- Medi-Flex(TM) recently announced an extension of its ChloraPrep(R) patient preoperative skin preparation line with the addition of new Hi-Lite Orange(TM) tinted ...

California-based CareFusion (NYSE:CFN) posted a strong 3rd quarter and narrowed its full-year sales outlook, touting strong sales growth, even for its controversial ChloraPrep surgical wipes. The ...

CareFusion launched its ChloraPrep1 mL applicator, the newest addition to the ChloraPrep line of preoperative skin preparation products. The applicator provides clinicians with the same formulation as ...

Becton, Dickinson and Company announced a voluntary recall for ChloraPrep 3 mL applicators in Guam and other territories after the company found the applicator may develop fungal contamination when it ...

EL PASO, Texas (KVIA) -- BD (Becton, Dickinson and Company) celebrated a vital medical product manufactured in El Paso. ChloraPrep cleans the skin in preparation for numerous procedures, from routine ...

BD’s ChloraPrep 1mL applicators are developed for preparing the patient’s skin before surgery. Credit: BD. BD has announced a voluntary worldwide recall of a single lot of ChloraPrep Clear 1mL ...

ONTARIO: According to research that was published in the Canadian Journal of Surgery, patients who were randomly assigned to receive DuraPrep had a considerably lower incidence of positive skin ...

1. In patients undergoing elective total hip arthroplasty, this randomized trial found that the most common bacterial organisms prior to skin preparation were coagulase-negative staph. 2. Following ...

SAN DIEGO, July 31, 2014 /PRNewswire/ -- CareFusion (NYSE:CFN), a leading global medical technology company, today announced the launch of its ChloraPrep ® 1 mL applicator, the newest addition to the ...

Editors at the New England Journal of Medicine are reviewing the publication of data from a 2010 study on CareFusion‘s (NYSE:CFN) ChloraPrep antiseptic, prompted by a federal complaint that called the ...